Comera Life Sciences Holdings, Inc.
Symbol: CMRA
NASDAQ
0.02684
USDMarktpreis heute
-0.0074
P/E-Verhältnis
0.0000
PEG-Verhältnis
0.83M
MRK Kapital
- 0.00%
DIV Rendite
Comera Life Sciences Holdings, Inc. (CMRA) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 0 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 0 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 0 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 0 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 0 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 0 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 0 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 0 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 0 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 0 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 0 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | 0 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | 0 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 0 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | 0 | 0.3 | -6.2 | 0 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | 0 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 0 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 0 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | 0 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 0 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | 0 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 0 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | 0 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | 0 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 0 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 0 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | 0 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | 0 | -9.8 | -3.9 | -1.8 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 0 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 0 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 0 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||
income-statement-row.row.operating-income | 0 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | 0 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 0 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | 0 | -24 | -5.3 | -2.1 |
Häufig gestellte Frage
Wie hoch ist die Comera Life Sciences Holdings, Inc. (CMRA) Gesamtvermögen?
Comera Life Sciences Holdings, Inc. (CMRA) Gesamtvermögen ist 3727113.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.735.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -1.529.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -84.219.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -9.143.
Was ist der Comera Life Sciences Holdings, Inc. (CMRA) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -24038181.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 775048.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 12392727.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.